Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
07/03/2003 | WO2003054157A2 Dna encoding novel cyclic gmp dependent protein kinases from two protozoal sources for use as chemotherapeutic targets for antiprotozoal agents |
07/03/2003 | WO2003054156A2 Novel g proein-coupled receptor, gave7 |
07/03/2003 | WO2003054153A2 Apyrase polypeptides and nucleic acids encoding same |
07/03/2003 | WO2003054152A2 Novel nucleic acids and polypeptides |
07/03/2003 | WO2003054142A2 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
07/03/2003 | WO2003054019A2 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases |
07/03/2003 | WO2003054018A2 Anti-tirc7 antibodies in therapy of inflammatory diseases |
07/03/2003 | WO2003054012A2 Leptin proteins |
07/03/2003 | WO2003053921A2 Mutant proteinase inhibitors and uses thereof |
07/03/2003 | WO2003053461A2 Lactic acid bacteria for preventing infection with intimin expressing pathogens |
07/03/2003 | WO2003053459A2 Differential induction, maintenance and regulation of cd8+ t cell response against a model antigen expressed by an acute versus a chronic intracellular bacterium |
07/03/2003 | WO2003053224A2 Novel compositions and methods for cancer |
07/03/2003 | WO2003053220A2 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease |
07/03/2003 | WO2003053161A1 Microorganism for the biological detoxification of mycotoxins, namely ochratoxins and/or zearalenones, and corresponding method and use |
07/03/2003 | WO2003053158A2 Malleable protein matrix and uses thereof |
07/03/2003 | WO2003053135A1 Plant xrcc3 genes and methods of use |
07/03/2003 | WO2003031590A3 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same |
07/03/2003 | WO2003026767A3 Lysin-deficient bacteriophages having reduced immunogenicity |
07/03/2003 | WO2003018788A3 Improved nitroreductase enzymes |
07/03/2003 | WO2002101009A3 Structural and cytoskeleton-associated proteins |
07/03/2003 | WO2002090495A8 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins |
07/03/2003 | WO2002074942B1 Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics |
07/03/2003 | WO2002070549A3 Chimeric polypeptides of serum albumin and uses related thereto |
07/03/2003 | WO2002050285A3 Histone deacetylase-related gene and protein |
07/03/2003 | WO2002050279A3 Nucleic acid-associated proteins |
07/03/2003 | WO2002042776A3 Compositions and methods relating to prostate specific genes and proteins |
07/03/2003 | WO2002036761A3 Compositions and methods for the diagnosis of cancer |
07/03/2003 | WO2002031203A9 High throughput or capillary-based screening for a bioactivity or biomolecule |
07/03/2003 | WO2002026804A3 84241, a human ring finger family member and uses thereof |
07/03/2003 | WO2002024733A3 Human polynucleotides and polypeptides encoded thereby |
07/03/2003 | WO2002006317A3 Compositions and methods for the therapy and diagnosis of ovarian cancer |
07/03/2003 | US20030126643 Manipulation of cellulose and/or beta-1,4-glucan |
07/03/2003 | US20030126641 Expression of fructose 1,6 bisphosphate aldolase in transgenic plants |
07/03/2003 | US20030126640 Genes for plant fatty acid modifying enzymes associated with conjugated double bond formation |
07/03/2003 | US20030126636 Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use |
07/03/2003 | US20030126630 Plant sterol reductases and uses thereof |
07/03/2003 | US20030126628 Avian oviduct regulatory sequences for controlling expression of interferon in transgenic cells; bioreactors |
07/03/2003 | US20030125537 Neovascularization; platelet derived growth factors; vascular permeability factors; wound healing agents; antitumor/antiproliferative agents; antisense agents; for treatment of intestinal malabsorption syndrome |
07/03/2003 | US20030125536 Fusion proteins/antigen presenting cells for promoting expansion of lymphocytes; vaccines |
07/03/2003 | US20030125534 Nucleotide sequences coding hydrolases for use in cleaning agents, detergents, textile treatment, baking, inking recycled paper, animal feeds, beverages and in the oilfield industry |
07/03/2003 | US20030125533 Regulation of human sphingosine kinase-like protein |
07/03/2003 | US20030125522 Novel peptides conferring environmental stress resistance and fusion proteins including said peptides |
07/03/2003 | US20030125519 Ligand for the c-kit receptor and methods of use thereof |
07/03/2003 | US20030125381 With halogenated furanones and related 3-haloalkenones |
07/03/2003 | US20030125375 Eurotinones, and derivatives thereof, processes for preparing them, and their use |
07/03/2003 | US20030125282 Treating fertility disorders; maternal-antigen-that-embryos-require (MATER) |
07/03/2003 | US20030125262 Methods and reagents for regulation of cellular responses in biological systems |
07/03/2003 | US20030125248 Novel bone mineralization proteins, DNA, vectors expression systems |
07/03/2003 | US20030125247 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
07/03/2003 | US20030125232 Stabilized proteins with engineered disulfide bonds |
07/03/2003 | US20030124725 Genetrating genomic rearangements in oncogenes; antitumor agents; cancer diagnosis |
07/03/2003 | US20030124707 Acetamidases for use as reporter gene in cell transformations; homologous recombination; gene replacement therapy |
07/03/2003 | US20030124704 Neuroprotectants; inhibition of axonal growth; antitumor agents |
07/03/2003 | US20030124700 Penicillium hydrolases for use in preparation of animal feeds |
07/03/2003 | US20030124698 Which stereoselectively hydrolyze nitrites or cyanohydrins into acids and ammonia |
07/03/2003 | US20030124697 Enzymatic protein for use in preparation of pantothenic acid and pantethine; vitamins |
07/03/2003 | US20030124695 Genes encoding baeyer-villiger monooxygenases |
07/03/2003 | US20030124692 Polyhydroxyalkanoate synthase and gene encoding the same |
07/03/2003 | US20030124691 Method for producing amide compounds |
07/03/2003 | US20030124690 Novel compounds |
07/03/2003 | US20030124689 Mitomycin biosynthetic gene cluster |
07/03/2003 | US20030124688 Microorganism producing l-lysine and processes for producing l-lysine using the same |
07/03/2003 | US20030124687 LysE proteins; fermentation; animal feeds; dihydrodipicolinate synthases; amino acid biosynthesis |
07/03/2003 | US20030124686 Method for producing L-arginine |
07/03/2003 | US20030124685 Carbamoyl-phosphate synthetase gene of coryneform bacteria and method for producing l-arginine |
07/03/2003 | US20030124684 Method for producing gamma-glutamylcysteine |
07/03/2003 | US20030124682 Fermenting vitamin b5 for use in animal feeds; nutrients; peptidase B; decarboxylases; transferases; synthetases |
07/03/2003 | US20030124681 Process for the preparation of D-pantothenic acid and/or salts thereof |
07/03/2003 | US20030124680 Genetic engineering of polyketide synthases; erythromycins; drug screening and delivery |
07/03/2003 | US20030124679 Bactericides; antitumor agents |
07/03/2003 | US20030124677 Amino-terminally truncated MCP-2 as chemokine antagonists |
07/03/2003 | US20030124676 Increasing production of proteins in gram-positive microorganisms |
07/03/2003 | US20030124675 Isolated CDNA encoding tumor necrosis factor binding protein II, its purification, and vectors, hosts and processes using such cDNA |
07/03/2003 | US20030124674 Batch fermentation of polypeptides; cosmetics; foods; medicines |
07/03/2003 | US20030124664 Aminopeptidase |
07/03/2003 | US20030124658 Molecular display on multmeric protein scaffolds derived from the e2 component of the alphaketoacid dehydrogenase |
07/03/2003 | US20030124655 Receptor protein specifically recognizing bacterial dna |
07/03/2003 | US20030124649 Membrane associated proteins |
07/03/2003 | US20030124644 Antibiotic production |
07/03/2003 | US20030124634 Novel proteins involved in the synthesis and assembly of O-antigen in pseudomonas aeruginosa |
07/03/2003 | US20030124607 Methods related to streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
07/03/2003 | US20030124602 Tumour suppresor and uses thereof |
07/03/2003 | US20030124598 PGC-1beta, a novel PGC-1 homologue and uses therefor |
07/03/2003 | US20030124597 Compositions and methods for identifying agents which regulate autolytic processes in bacteria |
07/03/2003 | US20030124587 Human tyrosine-DNA phosphodiesterase variant polypeptides and methods of use therefor |
07/03/2003 | US20030124582 Polypeptide encoded by a polynucleotide of given sequence; detecting the effect of a test compound on the production of mRNA; use in identifying agonists/antagonists that may be useful in therapy |
07/03/2003 | US20030124575 Dendritic cells; antigen presenting cells; g-protein coupled receptors; immunotherapy; antiinflammatory agents; antitumor agents; viricides; drug screening |
07/03/2003 | US20030124567 Use of a leptospire protein preventing and/or diagnosing and/or treating animal or human leptospirosis |
07/03/2003 | US20030124559 Rna polymerases from bacteriophage phi 6-phI 14 and use thereof |
07/03/2003 | US20030124555 Compositions and methods for use in isolation of nucleic acid molecules |
07/03/2003 | US20030124546 Fragments of nucleic acids specific to mycobacteria which are members of the M. tuberculosis complex and their applications for the detection and the differential diagnosis of members of the M. tuberculosis complex |
07/03/2003 | US20030124538 Reverse two-hybrid systems |
07/03/2003 | US20030124537 Procaryotic libraries and uses |
07/03/2003 | US20030124534 Measuring expression of nucleotide sequences in cells |
07/03/2003 | US20030124529 Pregnancy-associated plasma protein-A2 (PAPP-A2) |
07/03/2003 | US20030124507 Method of generating conditionally expressed mutant cells using expressible antisense sequences |
07/03/2003 | US20030124169 Biocompatible, biodegradable matrix and a protein, produced by expression of recombinant DNA capable of inducing endochondral bone formation in association with said matrix |
07/03/2003 | US20030124141 Helicobacter polypeptides and corresponding polynucleotide molecules |
07/03/2003 | US20030124137 For use in combatting a parasitic infestation of helminths; preferably of Fasciola or Dicrocoelium origin |
07/03/2003 | US20030124129 Angiopoietin-2 specific binding agents |